China and India Manufacturing: Risks and FDA Monitoring in Pharmaceuticals
China and India dominate global pharmaceutical manufacturing, but their regulatory risks and FDA inspection outcomes differ sharply. India leads in compliance and FDA approvals, while China dominates in volume - but with higher violation rates. Here’s what it means for drug safety.
